fashion -WSS

fashion

author：knowledge 2025-09-29 04:51:16 - browse：9426

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

knowledge

WSS

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

General Catalyst, Summa Health deal will turn on physician buy

Apple Vision Pro: A first look at health apps on the new VR headset

Vertigo drug brings hope for rare neuron disorder, Niemann

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

What does generative AI mean for health care? We asked experts

Vertigo drug brings hope for rare neuron disorder, Niemann

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Apple is now the first public company to be valued at $3 trillion

Do digital therapeutics have a future in medicine?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Quicker fix for pulse oximeters urged during FDA public meeting

Anesthesiologist group: stop taking Ozempic before surgery

HIV drugs protect against transmission, even in unprotected sex

hotspot

Change Healthcare can notify patients about the breach, HHS says

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Intellia reports positive results for its CRISPR

FDA drug safety: Singulair case shows systemic surveillance flaws

Quicker fix for pulse oximeters urged during FDA public meeting

How to increase colonoscopy rates? Looks like an AI can help

knowledge

focus

hotspot

knowledge